MIDS

Glooko receives FDA clearance for mobile insulin titration tool
By Dave Muoio | 11:55 am | February 14, 2018
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.